BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 22950342)

  • 1. Next generation natriuretic peptide measurement.
    Hunter I; Goetze JP
    Adv Clin Chem; 2012; 58():45-8. PubMed ID: 22950342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating forms of the b-type natriuretic peptide prohormone: pathophysiologic and clinical considerations.
    Clerico A; Vittorini S; Passino C
    Adv Clin Chem; 2012; 58():31-44. PubMed ID: 22950341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemistry of pro-B-type natriuretic peptide-derived peptides: the endocrine heart revisited.
    Goetze JP
    Clin Chem; 2004 Sep; 50(9):1503-10. PubMed ID: 15265821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Better treatment of heart failure by measurements of natriuretic peptides. There are still remaining problems when it comes to the interpretation of measurement levels].
    Lindstedt G; Dahlström U; Fernlund P; Schaufelberger M; Stridsberg M
    Lakartidningen; 2001 Oct; 98(41):4444-8, 4450-2. PubMed ID: 11699251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-type natriuretic peptide: from posttranslational processing to clinical measurement.
    Goetze JP
    Clin Chem; 2012 Jan; 58(1):83-91. PubMed ID: 22126935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Atrial natriuretic peptides: diagnostic and therapeutic potential].
    Brockhoff C; Warnholtz A; Münzel T
    Ther Umsch; 2000 May; 57(5):305-12. PubMed ID: 10859990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endocrine paradox in heart failure: resistance to biological effects of cardiac natriuretic hormones.
    Clerico A; Emdin M
    Clin Chem; 2004 Dec; 50(12):2465-7; author reply 2467-8. PubMed ID: 15563503
    [No Abstract]   [Full Text] [Related]  

  • 8. [Natriuretic peptides--when should they be used in heart failure?].
    Rottlaender D; Michels G; Hoppe UC
    Dtsch Med Wochenschr; 2008 Feb; 133(5):196-200. PubMed ID: 18213553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath.
    Lainchbury JG; Campbell E; Frampton CM; Yandle TG; Nicholls MG; Richards AM
    J Am Coll Cardiol; 2003 Aug; 42(4):728-35. PubMed ID: 12932611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unraveling the Molecular Complexity of O-Glycosylated Endogenous (N-Terminal) pro-B-Type Natriuretic Peptide Forms in Blood Plasma of Patients with Severe Heart Failure.
    Halfinger B; Hammerer-Lercher A; Amplatz B; Sarg B; Kremser L; Lindner HH
    Clin Chem; 2017 Jan; 63(1):359-368. PubMed ID: 28062629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Contra: Natriuretic peptides as diagnostic tool. Still obstacles for routine use in heart failure].
    Lindstedt G
    Lakartidningen; 2006 Mar 22-28; 103(12):930-2, 934-7. PubMed ID: 16618037
    [No Abstract]   [Full Text] [Related]  

  • 12. Atrial natriuretic peptides in heart failure: pathophysiological significance, diagnostic and prognostic value.
    Ghosh N; Haddad H
    Can J Physiol Pharmacol; 2011 Aug; 89(8):587-91. PubMed ID: 21806511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemistry of the human B-type natriuretic peptide precursor and molecular aspects of its processing.
    Semenov AG; Seferian KR
    Clin Chim Acta; 2011 May; 412(11-12):850-60. PubMed ID: 21396929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: analytical issues for biomarkers of heart failure.
    Apple FS; Wu AH; Jaffe AS; Panteghini M; Christenson RH; ;
    Clin Biochem; 2008 Mar; 41(4-5):222-6. PubMed ID: 18035345
    [No Abstract]   [Full Text] [Related]  

  • 15. Natriuretic Peptides in Heart Failure: Atrial and B-type Natriuretic Peptides.
    Maisel AS; Duran JM; Wettersten N
    Heart Fail Clin; 2018 Jan; 14(1):13-25. PubMed ID: 29153197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Brain natriuretic peptide as marker and factor of prognosis in chronic heart failure].
    Bugrimova MA; Savina NM; Vanieva OS; Sidorenko BA
    Kardiologiia; 2006; 46(1):51-7. PubMed ID: 16474311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unraveling the complexity of circulating forms of brain natriuretic peptide.
    Gundry RL; Van Eyk JE
    Clin Chem; 2007 Jul; 53(7):1181-2. PubMed ID: 17582147
    [No Abstract]   [Full Text] [Related]  

  • 18. Measurement and significance of circulating natriuretic peptides in cardiovascular disease.
    Sagnella GA
    Clin Sci (Lond); 1998 Nov; 95(5):519-29. PubMed ID: 9791037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro-B-type natriuretic peptide levels in acute decompensated heart failure.
    Waldo SW; Beede J; Isakson S; Villard-Saussine S; Fareh J; Clopton P; Fitzgerald RL; Maisel AS
    J Am Coll Cardiol; 2008 May; 51(19):1874-82. PubMed ID: 18466803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of brain natriuretic peptide (BNP) measurement in cardiovascular disease.
    Sullivan DR; West M; Jeremy R
    Heart Lung Circ; 2005 Jun; 14(2):78-84. PubMed ID: 16352258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.